Multidisciplinary Management of HCC in Elderly Patients
Multidisciplinary HCC Treatment in Elderly : QoL and Survival Analysis
1 other identifier
observational
126
1 country
1
Brief Summary
Aim of this study is to evaluate whether treating HCC recurrences in resected elderly patients is advantageous or not.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2018
CompletedFirst Submitted
Initial submission to the registry
March 10, 2019
CompletedFirst Posted
Study publicly available on registry
March 14, 2019
CompletedMarch 14, 2019
March 1, 2019
5 months
March 10, 2019
March 12, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Overall survival
survival in months
follow up time 1-16 years
Disease free survival
survival without recurrences in months
follow up time 1-16 years
Secondary Outcomes (6)
Karnofsky performance scale
follow up time 1-16 years
Activity of Daily living
follow up time 1-16 years
Instrumental Activity of Daily living
follow up time 1-16 years
Blood Haemoglobin
follow up time 1-16 years
serum Albumin
follow up time 1-16 years
- +1 more secondary outcomes
Study Arms (2)
Group A
Patients who developed HCC recurrences after surgery and treated with re-resection, or microinvasive non-surgical means.
Group B
Patients who did not develop recurrences after surgery.
Interventions
ablation of HCC nodule through a percutaneous needle, by using radiofrequency or microwaves
embolization of HCC nodule via drug-eluted microbeads.
Eligibility Criteria
all patients submitted to surgery for HCC nodules resection between 2002 and 2017
You may qualify if:
- HCC patient
- eligible for surgery
You may not qualify if:
- non eligible for surgery at first HCC diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery "Pietro Valdoni"
Roma, 00161, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefania Brozzetti, Professor
Policlinico Umberto I - Sapienza università di Roma
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 10, 2019
First Posted
March 14, 2019
Study Start
January 1, 2018
Primary Completion
May 30, 2018
Study Completion
October 31, 2018
Last Updated
March 14, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share